Clinical Trials Directory

Trials / Completed

CompletedNCT00127348

Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness

Effect of CPAP on Arterial Hypertension and Cardiovascular Morbi-Mortality in Patients With Sleep Apnea and Without Daytime Sleepiness

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
700 (planned)
Sponsor
Sociedad Española de Neumología y Cirugía Torácica · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to evaluate the effect of CPAP over the incidence of cardiovascular events and diagnosis of arterial hypertension in patients with sleep apnea. The hypothesis of the study is the following: The existence of sleep disordered breathing in the general population is associated to an increased incidence of arterial hypertension and to an increased risk of suffering cardiovascular disease. CPAP corrects respiratory disorders during sleep. Treatment with CPAP in subjects with sleep disordered breathing without daytime sleepiness reduces the incidence of systemic arterial hypertension and cardiovascular complications. The end points of the study are new diagnosis of arterial hypertension and new cardiovascular events. All patients, after randomization, will be followed for three years.

Conditions

Interventions

TypeNameDescription
DEVICECPAP (Continuous Positive Airway Pressure)

Timeline

Start date
2004-05-01
Completion
2006-04-01
First posted
2005-08-05
Last updated
2007-04-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00127348. Inclusion in this directory is not an endorsement.